UK-based Storm Therapeutics, which focuses on developing small molecule drugs that target RNA-modifying enzymes, has raised 12 million pounds in Series A funding. The investors were Imperial Innovations, Cambridge Innovation Capital, Merck Ventures and Pfizer Venture Investments.
5 min read · 28 June 2016
Bee Partners has raised over $30 million for its oversubscribed second fund, beating its initial $25 million target, according to a blog post on its site. The fund will focus on early-stage startups.
1 min read · 27 June 2016
3D printing startup Arevo has raised $7 million in Series A funding. Khosla Ventures led the round. In conjunction with the funding, Vijit Sabnis of Khosla Ventures has been added to Arevo's board of directors.
1 min read · 27 June 2016
Affiris AG, an Austrian developer of therapeutic peptide vaccines against chronic diseases, has secured 10 million euros in funding. The investors included FCPB Affi GmbH. Also, the company has named Günther Staffler as chief technology officer.
1 min read · 27 June 2016
Geospatial big data company Orbital Insight has raised $15 million in Series B funding. GV led the round with participation from CME Ventures, Sequoia Capital, Lux Capital and Bloomberg Beta.
1 min read · 27 June 2016
Research Triangle, North Carolina-based ZynBit.com, a provider of sales acceleration software, has secured $500,000 in funding. Sandy Roberson of Healthview Capital led the round. The capital infusion will be used for marketing and product development. A previous report of this item misidentified the investors in this funding. It has since been corrected.
2 min read · 27 June 2016
Vagabond Vending, a provider of route management and data analytics tools for vending machine operators, has secured more than $3 million in funding. The investors included Middleburg Capital Development, IrishAngels and Blu Venture Investors.
1 min read · 27 June 2016
Resin.io, a provider of modern DevOps management platform for connected devices, has raised $9 million in funding. The investors were DFJ, GE Ventures, Ericsson and Aspect Ventures.
3 min read · 27 June 2016
New York City-based Progyny, a digital healthcare company, has raised $14.7 million in Series B funding. An unnamed family office led the round with participation from Kleiner Perkins Caufield and Byers, Mellon, SR One, TPG Biotech and Union Grove Venture Partners.
3 min read · 26 June 2016
Yumanity Therapeutics, a drug developer focused on diseases caused by protein misfolding, has raised $45 million in Series A funding. Fidelity Management & Research Company led the round with participation from Redmile Group, Alexandria Venture Investments, Biogen, Sanofi-Genzyme BioVentures and Dolby Family Ventures.
4 min read · 10 February 2016